Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESTASIS vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESTASIS vs REZAFUNGIN: Safety Overview

Metric RESTASIS REZAFUNGIN
Total FAERS Reports 1,158 108
Deaths Reported 0 12
Death Rate N/A 11.1%
Hospitalizations 5 20
Average Patient Age 66.9 yrs 53.8 yrs
% Female Patients N/A 54.3%
FDA Approval Date N/A Mar 22, 2023
Manufacturer N/A Melinta Therapeutics, LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription